Needham Reiterates Buy on Alkami Technology, Maintains $20 Price Target
Needham analyst Mayank Tandon reiterates Alkami Technology (NASDAQ:ALKT) with a Buy and maintains $20 price target.
Needham Reiterates Buy on Definitive Healthcare, Maintains $15 Price Target
Needham analyst Ryan MacDonald reiterates Definitive Healthcare (NASDAQ:DH) with a Buy and maintains $15 price target.
Needham Reiterates Buy on Universal Display, Maintains $148 Price Target
Needham analyst James Ricchiuti reiterates Universal Display (NASDAQ:OLED) with a Buy and maintains $148 price target.
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $25 price target.
HC Wainwright & Co. Reiterates Buy on Arvinas, Maintains $90 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Arvinas (NASDAQ:ARVN) with a Buy and maintains $90 price target.
HC Wainwright & Co. Reiterates Buy on C4 Therapeutics, Maintains $35 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates C4 Therapeutics (NASDAQ:CCCC) with a Buy and maintains $35 price target.
HC Wainwright & Co. Reiterates Buy on Kymera Therapeutics, Maintains $85 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Kymera Therapeutics (NASDAQ:KYMR) with a Buy and maintains $85 price target.
HC Wainwright & Co. Reiterates Buy on ReWalk Robotics, Maintains $3 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ReWalk Robotics (NASDAQ:RWLK) with a Buy and maintains $3 price target.
HC Wainwright & Co. Reiterates Buy on Insmed, Maintains $52 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Insmed (NASDAQ:INSM) with a Buy and maintains $52 price target.
Needham Reiterates Strong Buy on Infinera, Maintains $15 Price Target
Needham analyst Alex Henderson reiterates Infinera (NASDAQ:INFN) with a Strong Buy and maintains $15 price target.